Literature DB >> 6714440

New directions in pharmacogenetics: Introduction.

E S Vesell.   

Abstract

General principles were developed for the selection of subjects for pharmacogenetic investigations. Depending on the particular metabolic pathway involved, studies may require that subjects be under carefully controlled, homogeneous environmental conditions. Otherwise, segregation in families of some genetically transmitted traits can be concealed by effects from multiple host factors. Therefore, in some pharmacogenetic studies of pharmacokinetic variations, differences among subjects with respect to critical host factors can profoundly influence the results obtained and conclusions drawn.

Mesh:

Substances:

Year:  1984        PMID: 6714440

Source DB:  PubMed          Journal:  Fed Proc        ISSN: 0014-9446


  4 in total

1.  A new, sensitive graphical method for detecting deviations from the normal distribution of drug responses: the NTV plot.

Authors:  L Endrenyi; M Patel
Journal:  Br J Clin Pharmacol       Date:  1991-08       Impact factor: 4.335

Review 2.  From human genetics and genomics to pharmacogenetics and pharmacogenomics: past lessons, future directions.

Authors:  Daniel W Nebert; Ge Zhang; Elliot S Vesell
Journal:  Drug Metab Rev       Date:  2008       Impact factor: 4.518

3.  Relationship between the metabolism of antipyrine, hexobarbitone and theophylline in man as assessed by a 'cocktail' approach.

Authors:  J H Schellens; J H van der Wart; M Danhof; E A van der Velde; D D Breimer
Journal:  Br J Clin Pharmacol       Date:  1988-10       Impact factor: 4.335

4.  Scientific challenges and implementation barriers to translation of pharmacogenomics in clinical practice.

Authors:  Y W Francis Lam
Journal:  ISRN Pharmacol       Date:  2013-02-28
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.